MU Department of Medicine 2011-2013 Annual Report Feb. 2014 | Page 34

34 Annual Report University of Missouri- Columbia Research CONT. Cerner-Tiger Institute to develop and refine be utilized and recommend disposition of multiple clinical quality improvement tools in the electronic medical record to the patients within the University system initiatives that include a discharge standardize desired performance and to during their observation stay. Also, they summary quality improvement project, measure that performance. are developing a training program and a multidisciplinary team approach protocols for care providers to address and implementation of a protocol for treatment, disposition, and discharge evaluation and treatment of fragility recommendations. The physician fractures that improves outcomes, a assistants will evaluate the effectiveness of situational analysis of patient knowledge the tool and treatment with data collection regarding their heart failure diagnosis, over a 4-6 month period. MU hospitalists predictors of recurrent admissions for are involved in two pharmaceutical patients presenting with DKA or HHS and research studies in cooperation with the delirium in post-operative period (DPP) Clinical Research Center. in elderly patients with major hip or knee Our team of physician assistants is conducting a study of efficient healthcare for alcohol abuse patients to decrease readmission rates and institution costs. The plan is to utilize a screening tool to identify individuals with a primary diagnosis of alcohol intoxication who could be safely discharged after an observation period of 23 hours or less. They want to develop a protocol by which this tool will MU hospitalists are also involved in surgery. Spotlight Medicine and its basic and clinical science departments. Investigators from other schools and colleges at MU can benefit from the center’s resources, including the College of Veterinary Medicine, the College of Engineering, the Sinclair School of Nursing, the School of Health Professions and numerous other schools and colleges on campus. The CRC expands opportunities for existing core basic science and clinical science researchers, including drug and device development teams to link with clinicians and patients and translate scientific discoveries into clinical applications through all phases of clinical trials. The CRC also provides the space and environment to expand and pursue trainee education, including National Institutes of Health (NIH) The Clinical Research Center (CRC) is the focal point of University of Missouri’s efforts to develop clinical and translational science programs that improve health through research, education and public service. The Clinical Research Center expands the capacity of the university’s Institute for Clinical and Translational Science (ICATS) to transform scientific discoveries in laboratories on campus into products, services and practices that improve health for the people of Missouri and beyond. It provides enormous opportunity for clinicians, clinician investigators, and basic scientists in the Department of Medicine and beyond to expand their research investigational activities in a state-of-the-art research facility. It aims to facilitate the School of Medicine and Department of Medicine strategic planning goals to increase the quality and productivity of scientific research. The CRC benefits numerous investigators in the School of training programs to meet educational goals and expand the cadre of clinician scientists who can foster the expansion of clinical and translational research. It also aims to bring new informatics tools to increase the capacity to manage data sources and expand research opportunities and capacity. The Center is designed to allow programmatic growth as MU-ICATS continues to stimulate interdisciplinary science with improved infrastructure for clinical research programs. Another renovation will create the MU Center for Translational Biomedicine and will be under the management of the MU-ICATS leadership team. The MU Center for Translational Biomedicine will closely interact with the Clinical Research Center as life science researchers move their work from the pre-clinical stage into early-stage trials involving human participants. The CRC also aims to interact with investigators working within the areas of comparative effectiveness and community-based research to expand research in these areas. Honors + Awards Carla Dyer, MD Clinical Curriculum Innovation Award; Academy for Healthcare Fellowship in the American College of Physicians (FACP); Improvement Duncan Neuhauser Award for innovation in quality Department of Medicine Quality Improvement Champion; improvement and patient safety education Macy Faculty Scholars Program Finalist; Outstanding Pre-